Ownership history in BARCLAYS PLC · 84 quarters on record
This page tracks every 13F SEC filing in which BARCLAYS PLC reported a position in AMICUS THERAPEUTICS, INC. USD COM (FOLD). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | ADDED | 1,134,639 | +165,117 | +17.0% | 0.00% | $16.2M | $14.24 |
| 2025 Q3 | ADDED | 969,522 | +855,522 | +750.5% | 0.00% | $7.6M | $7.88 |
| 2025 Q3 | REDUCED | 114,000 | -1,068,735 | -90.4% | 0.00% | $898K | $7.88 |
| 2025 Q2 | ADDED | 1,182,735 | +546,637 | +85.9% | 0.00% | $6.8M | $5.73 |
As of 2025 Q4 — sorted by position size